Target intelligence / Profile preview

Tight junction protein complex at the blood–brain barrier (BBB-TJ complex)

Target
BBB-TJ complex
Molecular classification
Cell-cell junction, Protein complex, Barrier protein
01

Overview

The tight junction protein complex at the blood–brain barrier (BBB) is a specialized assembly of transmembrane and cytoplasmic proteins that seal the paracellular space between endothelial cells (PMID: 23415110). Key components include claudins (especially claudin-5), occludin, and junctional adhesion molecules (JAMs), which are linked to the actin cytoskeleton via zonula occludens (ZO) scaffolding proteins (PMID: 12535520). This complex is essential for maintaining the high electrical resistance and selective permeability of the BBB, protecting the brain from toxins and pathogens while regulating nutrient transport (PMID: 28844075). Dysfunction of these proteins is a hallmark of several neurological disorders, including stroke, multiple sclerosis, and Alzheimer's disease, where barrier breakdown contributes to edema and neurodegeneration (PMID: 30124561). In drug development, this complex is a target for transient modulation to allow the passage of large or polar therapeutic agents into the brain (PMID: 21917916). Conversely, stabilizing these junctions is a therapeutic strategy to treat conditions characterized by excessive BBB permeability and neuroinflammation (PMID: 19233542).

Other names
Blood-brain barrier tight junctionsBBB tight junctionParacellular barrier of the BBBCerebrovascular tight junctionEndothelial tight junction
02

Mechanism of action

Transient disruption of paracellular seals through osmotic stress, receptor-mediated signaling (e.g., Adenosine A2A or Bradykinin B2 agonism), or direct modulation of junctional proteins to facilitate drug delivery to the central nervous system (PMID: 21917916, StatPearls: Osmotic Diuretics).

03

Biological functions

Paracellular transport regulationBlood-brain barrier maintenanceCell polaritySignal transductionIon homeostasis
04

Disease associations

Alzheimer's diseaseMultiple sclerosisStrokeBrain tumorMeningitisNeuroinflammationEpilepsy
05

Safety considerations

Cerebral edemaNeurotoxicityIncreased intracranial pressureRisk of CNS infectionUncontrolled entry of plasma proteinsSeizures
06

Interacting drugs

Mannitol

5 more in the full profile.

07

Biomarkers

Claudin-5 (CLDN5)Occludin (OCLN)Zonula occludens-1 (ZO-1)CSF/serum albumin ratio (Qalb)Soluble Claudin-5

Beyond the preview

Go deeper on Tight junction protein complex at the blood–brain barrier (BBB-TJ complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tight junction protein complex at the blood–brain barrier (BBB-TJ complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call